Information for "Your Ibr7 byproduct regarding ibrutinib radiosensitizes pancreatic cancer malignancy tissues simply by downregulating pEGFR"

From EECH Central
Jump to: navigation, search

Basic information

Display titleYour Ibr7 byproduct regarding ibrutinib radiosensitizes pancreatic cancer malignancy tissues simply by downregulating pEGFR
Default sort keyYour Ibr7 byproduct regarding ibrutinib radiosensitizes pancreatic cancer malignancy tissues simply by downregulating pEGFR
Page length (in bytes)3,966
Page ID1410498
Page content languageEnglish (en)
Page content modelwikitext
Indexing by robotsAllowed
Number of redirects to this page0

Page protection

EditAllow all users (infinite)
MoveAllow all users (infinite)

Edit history

Page creatorRamiewarm19 (Talk | contribs)
Date of page creation15:00, 27 April 2024
Latest editorRamiewarm19 (Talk | contribs)
Date of latest edit15:00, 27 April 2024
Total number of edits1
Total number of distinct authors1
Recent number of edits (within past 90 days)1
Recent number of distinct authors1